The First Approved “Deuterated” Drug: A Short Review of the Concept
- 1 Neumentum, Inc., Palo Alto, CA, USA
- 2 Colleges of Pharmacy, University of Arizona, Tucson, AZ, USA
- 3 Temple University School of Pharmacy, Philadelphia, PA, USA
- 4 NEMA Research, Inc., Naples, FL, USA
- 5 NEMA Research, Inc., Naples, FL, USA
Abstract
The first “ deuterated ” drug has recently been approved by the U.S. FDA (Food & Drug Administration). A “ deuterated ” drug is a drug in which the hydrogen atom in one or more of the carbon-hydrogen bonds in its chemical structure is replaced by deuterium ( “ heavy hydrogen ” , a hydrogen isotope that has a neutron, i.e ., one neutron instead of the usual no neutrons). A carbon-deuterium (C - D) bond is more stable in the body than a carbon-hydrogen (C - H) bond. If the deuterium is strategically located in a drug’s chemical structure, the extra stability of the bond will be more resistant to metabolic breakdown, and the duration of drug action will be prolonged. We review the general concept of deuterated drugs, historical examples of the classes of application, and the new approval.
- Lin, J.H. and Lu, A.Y. (1997) Role of Pharmacokinetics and Metabolism in Drug Discovery and Development. Pharmacological Reviews, 49, 403-449. https://www.ncbi.nlm.nih.gov/pubmed/9443165
- Borowy, C.S. and Ashurst, J.V. (2018) Physiology, Zero and First Order Kinetics. In: Physiology, Zero and First Order Kinetics. Treasure Island (FL). https://www.ncbi.nlm.nih.gov/pubmed/29763041
- Greenberg, R.N. (1984) Overview of Patient Compliance with Medication Dosing: A Literature Review. Clinical Therapeutics, 6, 592-599. https://www.ncbi.nlm.nih.gov/pubmed/6383611
- Claxton, A.J., Cramer, J. and Pierce, C. (2001) A Systematic Review of the Associations between Dose Regimens and Medication Compliance. Clinical Therapeutics, 23, 1296-1310. https://www.ncbi.nlm.nih.gov/pubmed/11558866 https://doi.org/10.1016/S0149-2918(01)80109-0
- Schramm, V.L. (1998) Enzymatic Transition States and Transition State Analog Design. Annual Review of Biochemistry, 67, 693-720. https://www.ncbi.nlm.nih.gov/pubmed/9759501 https://doi.org/10.1146/annurev.biochem.67.1.693
- Blake, M.I., Crespi, H.L. and Katz, J.J. (1975) Studies with Deuterated Drugs. Journal of Pharmaceutical Sciences, 64, 367-391. https://www.ncbi.nlm.nih.gov/pubmed/1151621 https://doi.org/10.1002/jps.2600640306
- Dean, M. and Sung, V.W. (2018) Review of Deutetrabenazine: A Novel Treatment for Chorea Associated with Huntington’s Disease. Drug Design, Development and Therapy, 12, 313-319. https://www.ncbi.nlm.nih.gov/pubmed/29497277 https://doi.org/10.2147/DDDT.S138828